AbbVie (ABBV) EBITDA (2012 - 2026)
AbbVie's EBITDA was $8.33 billion in Q2 2026, up 19.3% from $6.98 billion a year earlier and up 40.5% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) EBITDA (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, AbbVie's EBITDA was $24.8 billion through Jun 30, 2026, up 28.3% year-over-year; for FY2025, it came in at $23.24 billion, up 32.6% from FY2024.
- EBITDA shows a five-year compound annual growth rate of 5.4% (FY2020 to FY2025).
- In earlier years, EBITDA was $17.52 billion in FY2024 (-18.3%), $21.46 billion in FY2023 (-19.3%), $26.6 billion in FY2022 (+0.6%) and $26.45 billion in FY2021 (+48.3%).
- The Q2 2026 figure marks the highest quarterly EBITDA in data going back to Q1 2012.
- Compared with a year earlier, EBITDA has increased for three straight quarters, with growth averaging 117.0% over the last eight quarters.
- The best year-over-year quarter for EBITDA over five years was Q4 2025 (growth of 969.8%); the worst was Q4 2024 (a decline of 88.3%).
- Per Business Quant data, ABBV's EBITDA in the three quarters before Q2 2026 was $5.93 billion (Q1 2026), $6.55 billion (Q4 2025) and $4 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 954.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.33 Bn |
| Mar 31, 2026 | 5.93 Bn |
| Dec 31, 2025 | 6.55 Bn |
| Sep 30, 2025 | 4.00 Bn |
| Jun 30, 2025 | 6.98 Bn |
| Mar 31, 2025 | 5.81 Bn |
| Dec 31, 2024 | 612.00 Mn |
| Sep 30, 2024 | 5.92 Bn |
| Jun 30, 2024 | 6.08 Bn |
| Mar 31, 2024 | 4.88 Bn |
| Dec 31, 2023 | 5.23 Bn |
| Sep 30, 2023 | 4.48 Bn |
| Jun 30, 2023 | 6.80 Bn |
| Mar 31, 2023 | 4.90 Bn |
| Dec 31, 2022 | 7.67 Bn |
| Sep 30, 2022 | 6.78 Bn |
| Jun 30, 2022 | 5.30 Bn |
| Mar 31, 2022 | 6.82 Bn |
| Dec 31, 2021 | 7.05 Bn |
| Sep 30, 2021 | 6.43 Bn |
API Access
AbbVie EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();